Skip to main content

Table 1 Clinicopathologic factors of 106 patients with 8th AJCC pathologic stage 0 or I esophageal squamous cell carcinoma

From: Similar survival after endoscopic submucosal dissection and esophagectomy in early esophageal cancer and synchronous or metachronous head and neck cancer

Factors

No. of patients (Percentage)

Age (years) (range: 40–80, mean: 55.36, median: 55)

 

Current smoker

 

 Yes

23 (21.7%)

 No

83 (78.3%)

Comorbidity (diabetes mellitus, liver cirrhosis, hypertension, esophageal reflux disease, CAD)

 

 0

51 (48.1%)

 1

55 (51.9%)

Clinical 8th AJCC stage

 

 0

10 (9.4%)

 I

80 (75.5%)

 II

14 (13.2%)

 III

2 (1.9%)

Clinical T stage

 

 0 (Tis)

11 (10.4%)

 T1

79 (74.5%)

 T2

16 a(15.1%)

Clinical N stage

 

 N0

97 (91.5%)

 N1

7 (6.6%)

 N2

2 (1.9%)

Primary tumor location

 

 Upper

21 (19.8%)

 Middle

53 (50.0%)

 Lower

32 (30.2%)

Pathological tumor grade

 

 0 (Tis)

13 (12.3%)

 1

8 (7.5%)

 2

78 (73.6%)

 3

7 (6.6%)

Synchronous head and neck cancer

 

 No

53 (50.0%)

 Yes

53 (50.0%)

Metachronous head and neck cancer

 

 No

87 (82.1%)

 Yes

19 (17.9%)

  1. AJCC, American Joint Committee on Cancer